Zentiva

Zentiva is a pan-European pharmaceutical platform that develops, manufactures, and supplies high-quality, affordable medicines to over 100 million people across Europe. With four fully owned manufacturing sites and a robust network of external partners, the company ensures supply security while delivering products in key therapeutic areas such as cardiology & circulation, diabetes, oncology, respiratory, CNS, and an expanding self-care portfolio. Backed by private-equity ownership, Zentiva is committed to sustainable double-digit growth and has a five-year strategy that blends organic expansion with strategic acquisitions across the continent. Employing more than 5,000 professionals, the organization prioritizes an inclusive culture that empowers employees to contribute authentically to the mission of improving health and well-being for all generations.